It is one of the main GBCA associated with nephrogenic systemic fibrosis (NSF), a toxic reaction occurring in some people with kidney problems. No cases have been seen in people with normal kidney function. A 2015 study found gadolinium deposited in the brain tissue of people who had received<unk> . Other studies using post-mortem mass spectrometry found most of the deposit remained at least 2 years after an injection and deposit also in individuals with no kidney issues. In vitro studies found it to be neurotoxic. An Italian task force recommended that breastfeeding mothers precautionally avoid any contrast agent such as<unk>  that has been associated with nephrogenic systemic fibrosis.
Gadodiamide
Indapamide
Iohexol
Dauricine
Iodixanol
Flonicamid
Glycidamide
Bumetanide